Clinical Trials Browser

Phase 2 × Lymphoma, Mantle-Cell × Interleukin-2 × Clear all

NCT00101101 2023-08-22

Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma

Phase 2 Completed

43 enrolled 7 charts

Lymphoma, Lymphoma, Mantle-Cell